NCT04017637

Brief Summary

Evaluate feasibility, safety, and preliminary estimates of resistance training (RT) efficacy to promote lean body mass accrual in patients with CD aged 14-18. This will be achieved by conducting a parallel 2-arm randomized-controlled pilot trial of RT compared to usual care. At weeks 0 (pre-treatment), 6 (mid-treatment), and 12 (post- treatment), feedback regarding safety, feasibility, and acceptability will be collected from participants through surveys and interviews. Magnitude of the effect size of the intervention on LBM, muscle strength, and health-related quality of life (HRQoL) will also be estimated.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 12, 2019

Completed
8 months until next milestone

Study Start

First participant enrolled

March 6, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 6, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 6, 2020

Completed
Last Updated

June 2, 2020

Status Verified

May 1, 2020

Enrollment Period

Same day

First QC Date

July 8, 2019

Last Update Submit

May 29, 2020

Conditions

Keywords

Inflammatory Bowel DiseaseResistance TrainingLean Body MassPediatric

Outcome Measures

Primary Outcomes (3)

  • Change in body composition as measured by DEXA

    12 weeks

  • Change in muscle strength as measured using a hand dynamometer

    12 weeks

  • Change in Health-related quality of life as measured by the PedsQL4.0

    12 weeks

Secondary Outcomes (1)

  • Change in Disease Activity as measured by C-reactive protein blood test

    12 weeks

Other Outcomes (1)

  • Total number of intervention sessions attended

    12 weeks

Study Arms (2)

Usual Care (UC)

NO INTERVENTION

Those randomized to the UC group will complete baseline and post-intervention assessments only. No intervention will be administered.

Resistance Training Intervention (RT)

EXPERIMENTAL

Those randomized to the RT group will complete baseline and post-intervention assessments at weeks 0 and 12. For the intervention, they will complete resistance training for approximately 12 minutes 2x per week for 12 weeks.

Behavioral: Resistance Training

Interventions

Static resistance training including two arm and two leg movements will be performed twice per week for 12 weeks.

Resistance Training Intervention (RT)

Eligibility Criteria

Age14 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • aged 14-18
  • diagnosed with Crohn's Disease
  • able to read, write, and speak English
  • have a consenting caregiver who can commit to all study procedures
  • have clearance from their primary treating IBD physician to enroll in the RT intervention

You may not qualify if:

  • history of neuro-developmental or neuro-motor disorder (including but not limited to Intellectual Disability, Down Syndrome, or Cerebral Palsy)
  • presence of another medical condition that prevents them from being able to participate in physical activity
  • currently participating in a formal exercise or physical activity program beyond physical education offered at school
  • currently on systemic steroids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Parallel 2-arm randomized-controlled pilot trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 8, 2019

First Posted

July 12, 2019

Study Start

March 6, 2020

Primary Completion

March 6, 2020

Study Completion

March 6, 2020

Last Updated

June 2, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations